Genelux
phase pivotal trial design founded on phase trial design results trial design intends to replicate previous data showing anti tumor activity of and reversal of platinum resistance in the tumor poe | Genelux
Company
Deck Type
Sector
Industry
Deck date
February 2024
Slide
16 of 37
Similar slides by Genelux
See diffirences between slides (animation)
Investor Presentation
December 2023
phase pivotal trial design founded on phase trial design results trial design intends to replicate previous data showing anti tumor activity of and reversal of platinum resistance in the tumor | Genelux
Investor Presentation
October 2023
phase pivotal trial design founded on phase trial design results | Genelux
Investor Presentation
July 2023
phase pivotal trial design founded on phase trial design results | Genelux
Related slides by other companies
Aeglea BioTherapeutics
Investor Presentation
May 2023
phase clinical trial design | Aeglea BioTherapeutics
RayzeBio
IPO
September 2023
act phase trial design | RayzeBio
GH Research
Investor Presentation
November 2023
design of phase trial in healthy volunteers | GH Research
Calliditas Therapeutics
IPO
June 2020
phase trial design criteria | Calliditas Therapeutics
Other recent decks by Genelux
See all presentations (4 decks)
Investor Presentation
December 2023
Investor Presentation
October 2023
Investor Presentation
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io